Ozempic manufacturer Novo Nordisk said patient safety is a priority and “the benefit-risk profile of semaglutide remains ...
The European Union's drug regulator said it would assess two new Danish studies that link Novo Nordisk's popular diabetes ...
New studies link diabetes drug Ozempic to increased risk of NAION, a rare eye condition causing vision loss. Danish Medicines ...
According to its website, Novo Nordisk was founded in 1923 in Copenhagen, Denmark’s capital city. It is best known for ...
Danish health authorities said on Monday they would ask the European Union's drug regulator to review the findings of two ...
"An MDL that encompassed any potential injury relating to use of these exceedingly popular weight loss drugs might quickly ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback